Use of nnmt as a marker for lung cancer

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/574 (2006.01) C12Q 1/48 (2006.01)

Patent

CA 2655851

The present invention relates to the assessment of lung cancer. It discloses the use of protein NNMT in the assessment of lung cancer. It also relates to a method for assessing lung cancer by measuring NNMT in vitro in a liquid sample derived from an individual. Measurement of NNMT can, e.g., be used in the early detection or in the follow-up of patients with lung cancer.

La présente invention concerne l'évaluation du cancer du poumon. Elle concerne l'utilisation de la protéine NNMT pour l'évaluation du cancer du poumon. Elle concerne également un procédé permettant d'évaluer le cancer du poumon en mesurant la NNMT in vitro dans un échantillon liquide prélevé sur un individu. La mesure de la NNMT peut notamment être utilisée pour la détection précoce ou le suivi de patients atteints d'un cancer du poumon.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of nnmt as a marker for lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of nnmt as a marker for lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nnmt as a marker for lung cancer will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1778059

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.